Premium Celnalid 25mg UAE | Leading Pharmaceutical Exporter from India

Celnalid 25mg Capsule: High-Potency Immunomodulatory Therapy for Oncology & Hematology

Are you searching for a reliable Celnalid 25 mg capsule exporter from India? Ernest Oncology, a premier division of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier and bulk distributor of advanced hematological therapeutics. We provide a robust supply chain to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring that high-intensity oncology medications reach healthcare providers, hospitals, and specialized pharmacies with speed and regulatory precision.

Detailed Product Overview: What is Celnalid 25mg?

Celnalid 25mg is a high-strength oral antineoplastic medication containing the active ingredient Lenalidomide. It belongs to a specialized class of drugs known as Immunomodulatory Imides (IMiDs). Lenalidomide is chemically engineered to provide potent anti-tumor and immune-enhancing effects, specifically targeting malignant cells in the bone marrow and blood.

The 25mg strength is the standard starting dose for many intensive treatment protocols, particularly for newly diagnosed patients or those in the active induction phase of treatment for Multiple Myeloma.

Primary Therapeutic Indications: 

Celnalid 25mg is clinically indicated for several complex conditions:

• Multiple Myeloma (MM): Used as a foundational therapy in combination with dexamethasone for both newly diagnosed patients and those who have received at least one prior therapy.

• Mantle Cell Lymphoma (MCL): Indicated for adult patients whose disease has relapsed or progressed following two prior therapies (including bortezomib).

• Follicular Lymphoma (FL): Used in combination with a rituximab product for previously treated patients.

• Marginal Zone Lymphoma (MZL): Indicated for patients who require systemic therapy after prior treatment.

Mechanism of Action: How Celnalid 25mg Works:

Celnalid 25 mg operates through a multi-modal mechanism of action to eliminate cancer cells:

1. Direct Cytotoxicity: It binds to the protein cereblon, part of an enzyme complex that triggers the degradation of essential transcription factors (Aiolos and Ikaros), leading to the death of malignant B-cells.

2. Inhibition of Angiogenesis: It blocks the formation of new blood vessels (angiogenesis) within the bone marrow, effectively "starving" tumors of the oxygen and nutrients needed to grow.

3. Immune System Activation: It enhances the activity of Natural Killer (NK) cells and T-cells, empowering the body's own immune system to identify and destroy cancerous cells more effectively.

4. Cytokine Modulation: It alters the production of inflammatory cytokines, changing the bone marrow microenvironment to make it hostile for tumor survival.

Administration and Dosage: 

• Route: Oral administration (capsules).

• Standard Cycle: Often administered in 21-day or 28-day cycles, depending on the specific protocol (e.g., 21 days on, 7 days off).

• Instructions: Capsules must be swallowed whole with water at the same time each day. They should never be opened, chewed, or crushed.

Safety Profile & Safety Monitoring:

Healthcare professionals must implement strict monitoring for patients on Celnalid 25 mg:

• Embryo-Fetal Toxicity: Due to its structural similarity to thalidomide, it can cause severe birth defects. Strict adherence to pregnancy prevention programs (REMS) is mandatory.

• Hematologic Monitoring: Regular blood tests are required to monitor for Neutropenia (low white blood cells) and Thrombocytopenia (low platelets).

• Thrombosis Risk: Patients are at an increased risk of blood clots (DVT/PE); prophylactic anticoagulants are commonly prescribed.

• Common Side Effects: Diarrhea, fatigue, nausea, and itching/rashes.

Why source Celnalid 25 mg from Ernest Oncology?

• Verified Supply Chain: Direct procurement from GMP-certified facilities, ensuring 100% authenticity for every exporter from India shipment.

• Global Logistics Mastery: Expertise in handling international regulatory paperwork for the USA, UK, UAE, Australia, and South Africa 

• Bulk Availability: Consistent stock of 25mg capsules ensures that global distributors can fulfill large hospital tenders without delay.

• B2B Partnership Focus: Specialized wholesale pricing and track-and-trace logistics for international pharmaceutical distributors.